Literature DB >> 12557011

Severe depletion of mitochondrial DNA in spinal muscular atrophy.

Alexandra Berger1, Johannes A Mayr, David Meierhofer, Ulrike Fötschl, Reginald Bittner, Herbert Budka, Claude Grethen, Michael Huemer, Barbara Kofler, Wolfgang Sperl.   

Abstract

Spinal muscular atrophy (SMA) is a neuromuscular disorder in childhood leading to a dramatic loss of muscle strength. Functional investigations with high-resolution polarography and enzyme measurements of the respiratory chain revealed lowered activities in muscle tissue of SMA patients. To gain a better understanding of this low energy supply we analyzed the amount of mitochondrial DNA (mtDNA) in skeletal muscle of 20 unrelated children with genetically proven SMA and 31 controls. Quantitative Southern blot analysis revealed a severe and homogeneous decrease in the content of muscle mtDNA in relation to nuclear DNA in SMA patients (90.3+/-7.8%), whereas by immunofluorescence no decrease in the number of mitochondria was detected. In addition, a two- to threefold reduction of the nuclear-encoded complex II (succinate dehydrogenase) activity was detected in SMA muscle tissue. Western blot analysis showed a significant reduction of both mitochondrial- and nuclear-encoded cytochrome c oxidase subunits. Our results indicate that mtDNA depletion in SMA is a consequence of severe atrophy, and has to be differentiated by measurement of complex II from an isolated reduction of mtDNA as found in patients with mitochondriocytopathies and the so-called mtDNA depletion syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12557011     DOI: 10.1007/s00401-002-0638-1

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  Previously Unreported Biallelic Mutation in DNAJC19: Are Sensorineural Hearing Loss and Basal Ganglia Lesions Additional Features of Dilated Cardiomyopathy and Ataxia (DCMA) Syndrome?

Authors:  Sema Kalkan Ucar; Johannes A Mayr; René G Feichtinger; Ebru Canda; Mahmut Çoker; Saskia B Wortmann
Journal:  JIMD Rep       Date:  2016-12-08

Review 2.  Advances in therapy for spinal muscular atrophy: promises and challenges.

Authors:  Ewout J N Groen; Kevin Talbot; Thomas H Gillingwater
Journal:  Nat Rev Neurol       Date:  2018-02-09       Impact factor: 42.937

Review 3.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment.

Authors:  Dmitriy M Niyazov; Stephan G Kahler; Richard E Frye
Journal:  Mol Syndromol       Date:  2016-06-03

4.  Motor neuron mitochondrial dysfunction in spinal muscular atrophy.

Authors:  Nimrod Miller; Han Shi; Aaron S Zelikovich; Yong-Chao Ma
Journal:  Hum Mol Genet       Date:  2016-08-03       Impact factor: 6.150

5.  Nutritional practices at a glance: spinal muscular atrophy type I nutrition survey findings.

Authors:  Rebecca Hurst Davis; Barbara J Godshall; Erin Seffrood; Mary Marcus; Bernard A LaSalle; Brenda Wong; Mary K Schroth; Kathryn J Swoboda
Journal:  J Child Neurol       Date:  2013-10-04       Impact factor: 1.987

6.  Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice.

Authors:  Rocío Ruiz; Juan José Casañas; Laura Torres-Benito; Raquel Cano; Lucía Tabares
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

7.  Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma.

Authors:  Rene' G Feichtinger; Franz Zimmermann; Johannes A Mayr; Daniel Neureiter; Cornelia Hauser-Kronberger; Freimut H Schilling; Neil Jones; Wolfgang Sperl; Barbara Kofler
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

8.  Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy.

Authors:  Michela Ripolone; Dario Ronchi; Raffaella Violano; Dionis Vallejo; Gigliola Fagiolari; Emanuele Barca; Valeria Lucchini; Irene Colombo; Luisa Villa; Angela Berardinelli; Umberto Balottin; Lucia Morandi; Marina Mora; Andreina Bordoni; Francesco Fortunato; Stefania Corti; Daniela Parisi; Antonio Toscano; Monica Sciacco; Salvatore DiMauro; Giacomo P Comi; Maurizio Moggio
Journal:  JAMA Neurol       Date:  2015-06       Impact factor: 18.302

9.  Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations.

Authors:  Martina Huemer; Daniela Karall; Anna Schossig; Jose E Abdenur; Fatma Al Jasmi; Caroline Biagosch; Felix Distelmaier; Peter Freisinger; Brett H Graham; Tobias B Haack; Natalie Hauser; Jozef Hertecant; Darius Ebrahimi-Fakhari; Vassiliki Konstantopoulou; Karen Leydiker; Charles M Lourenco; Sabine Scholl-Bürgi; Ekkehard Wilichowski; Nicole I Wolf; Saskia B Wortmann; Robert W Taylor; Johannes A Mayr; Penelope E Bonnen; Wolfgang Sperl; Holger Prokisch; Robert McFarland
Journal:  J Inherit Metab Dis       Date:  2015-04-14       Impact factor: 4.982

10.  Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy.

Authors:  Jacqueline Montes; Ashley M Goodwin; Michael P McDermott; David Uher; Feliz Marie Hernandez; Kayla Coutts; Julia Cocchi; Margarethe Hauschildt; Kayla M Cornett; Ashwini K Rao; Umrao R Monani; Carol Ewing Garber; Darryl C De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2021-03-31       Impact factor: 5.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.